Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559663 · ClinicalTrials.gov registry record · NA
Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile
A NA study, sponsored by LifeBridge Health.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00559663: Completed NA study, sponsored by LifeBridge Health.
NCT00559663 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00559663, a NA study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of dark chocolate with green tea in healthy subjects on clot formation (platelet activity) cholesterol profile and markers of inflammation in two groups. The first group will be on a regimen of dark chocolate, and the second group will be on a regimen of green tea. Clinical outcomes will be determined after seven days of each treatment and both groups will undergo both treatments subsequently and serve as their own control. The hypothesis is that both green tea and dark chocolate will reduce platelet activity and reduce LDL, hsCRP and increase HDL.
Interventions
- DIETARY_SUPPLEMENT Green tea
- DIETARY_SUPPLEMENT 70% dark chocolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-04 |
| Phase | NA |
What the finished NCT00559663 record still lists
NCT00559663 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Green tea is the first listed.
NCT00559663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00559663 about?
NCT00559663 is a clinical study titled "Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile". The purpose of this study is to compare the effect of dark chocolate with green tea in healthy subjects on clot formation (platelet activity) cholesterol profile and markers of inflammation in two groups. The first group will be on a regimen of dark chocolate, and the second group will be on a regi...
What is the current status of trial NCT00559663?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2006-09. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00559663?
The interventions under investigation include: Green tea (DIETARY_SUPPLEMENT), 70% dark chocolate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00559663?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00559663's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia